LC-MS Research Scientist - Proteomics

Modern medicine development is trending towards developing personalised treatments for individual patients. As part of this research & development, innovative companies are developing complex assays that identify biomarkers for drug responses in clinical samples.

Our client, has identified unique protein signatures in clinical samples that have been verified as biomarkers for drug response. Using a range of high end mass spectrometry equipment, they have designed and developed novel biomarker assays that could be used in a clinical setting to analyse drug efficacy, ensuring that an effective treatment is prescribed more often.

You will be responsible for developing & optimizing these LC-MS biomarker methods, analysing complex data sets and contributing towards the continuous improvement of existing assays and taking a leading role in the development of novel assays to target new disease areas.

Candidates with the following experience will be considered for this role:

• PhD focused on mass spectrometry method development; ideally with a proteomics background, however metabolomics and lipidomic backgrounds will also be considered


• Experience of handling and working with biological/clinical samples e.g. cell lines, blood, tissue


• Excellent communication skills

The application process will follow a 2 stage interview process, starting with an initial chat with the hiring manager, followed by an onsite interview where you will prepare and deliver a presentation detailing your mass spectrometry experience to date.

Apply today for this unique opportunity!

Keywords: LC-MS, LC/MS, LCMS, mass spectrometry, proteomics, metabolomics, lipidomics, biomarkers, clinical, biological, method development, drug development, pharmaceutical, postdoctoral , postdoc, Manchester, Liverpool, Alderley Edge, VRS8624SE

Please note that by submitting your application to VRS Ltd your details will be registered with us so that we can contact you about suitable job opportunities now and in future. You may unsubscribe at any time by emailing us directly via our website